This activation may be a result of the loss of the tumor transformation suppressor PTEN and the TSC1/TSC2 complex, the amplification or mutation of genes encoding class I PI3K kinases, the overexpression of PKB/Akt, and exposure to carcinogens, as well as an increased activity of tyrosine kinase receptors. The gene discussed is AKT1; the disease is neoplasm.